Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Group IB
PROCEDURE
2 trials
Sponsors
Bagcilar Training and Research Hospital
, Swedish Institute for Infectious Disease Control
Conditions
Endothelial Dysfunction
HIV/AIDS
Ischemia Reperfusion
Oxidative Stress
Unknown Phase
TaMoVac-01
Active, not recruiting
PACTR2010050002122368
Swedish Institute for Infectious Disease Control
HIV/AIDS
Start: 2010-05-26
Target: 120
Updated: 2026-08-03
Effects of Anesthesia Technique on Endothelial Function
Completed
NCT06515028
Bagcilar Training and Research Hospital
Endothelial Dysfunction, Ischemia Reperfusion, Oxidative Stress
Start: 2024-08-25
End: 2025-01-30
Updated: 2026-05-07
Related Papers
Boosting with Subtype C CN54rgp140 Protein Adjuvanted with Glucopyranosyl Lipid Adjuvant after Priming with HIV-DNA and HIV-MVA Is Safe and Enhances Immune Responses: A Phase I Trial
PLoS ONE
2016-05-18
20 citations
Priming with a Simplified Intradermal HIV-1 DNA Vaccine Regimen followed by Boosting with Recombinant HIV-1 MVA Vaccine Is Safe and Immunogenic: A Phase IIa Randomized Clinical Trial
PLoS ONE
2015-04-15
43 citations